These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 8091657)
21. Small amino acid sequence changes within the V2 domain can affect the function of a T-cell line-tropic human immunodeficiency virus type 1 envelope gp120. Koito A; Stamatatos L; Cheng-Mayer C Virology; 1995 Feb; 206(2):878-84. PubMed ID: 7856100 [TBL] [Abstract][Full Text] [Related]
22. Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells. Zhu X; Borchers C; Bienstock RJ; Tomer KB Biochemistry; 2000 Sep; 39(37):11194-204. PubMed ID: 10985765 [TBL] [Abstract][Full Text] [Related]
23. Hydrophilicity dependent budding and secretion of chimeric HIV Gag-V3 virus-like particles. Luo L; Li Y; Ha SD; Kang CY Virus Genes; 2007 Oct; 35(2):187-93. PubMed ID: 17510784 [TBL] [Abstract][Full Text] [Related]
24. V3 loop sequence analysis of seven HIV type 1 group O isolates phenotyped in peripheral blood mononuclear cells and MT-2 cells. De Jong J; Simon F; Van der Groen G; Baan E; Saragosti S; Brun-Vézinet F; Goudsmit J AIDS Res Hum Retroviruses; 1996 Nov; 12(16):1503-7. PubMed ID: 8911575 [TBL] [Abstract][Full Text] [Related]
25. Site-specific N-glycosylation and oligosaccharide structures of recombinant HIV-1 gp120 derived from a baculovirus expression system. Yeh JC; Seals JR; Murphy CI; van Halbeek H; Cummings RD Biochemistry; 1993 Oct; 32(41):11087-99. PubMed ID: 8218172 [TBL] [Abstract][Full Text] [Related]
26. Role of HIV-1 envelope V3 loop cleavage in cell tropism. Gu R; Westervelt P; Ratner L AIDS Res Hum Retroviruses; 1993 Oct; 9(10):1007-15. PubMed ID: 8280475 [TBL] [Abstract][Full Text] [Related]
27. Mechanism of anti-HIV activity of succinylated human serum albumin. Kuipers ME; vd Berg M; Swart PJ; Laman JD; Meijer DK; Koppelman MH; Huisman H Biochem Pharmacol; 1999 Apr; 57(8):889-98. PubMed ID: 10086322 [TBL] [Abstract][Full Text] [Related]
28. Comparative Analysis of the Glycosylation Profiles of Membrane-Anchored HIV-1 Envelope Glycoprotein Trimers and Soluble gp140. Go EP; Herschhorn A; Gu C; Castillo-Menendez L; Zhang S; Mao Y; Chen H; Ding H; Wakefield JK; Hua D; Liao HX; Kappes JC; Sodroski J; Desaire H J Virol; 2015 Aug; 89(16):8245-57. PubMed ID: 26018173 [TBL] [Abstract][Full Text] [Related]
29. The intracellular production and secretion of HIV-1 envelope protein in the methylotrophic yeast Pichia pastoris. Scorer CA; Buckholz RG; Clare JJ; Romanos MA Gene; 1993 Dec; 136(1-2):111-9. PubMed ID: 8293993 [TBL] [Abstract][Full Text] [Related]
30. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein. Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of the contribution of the transmembrane region to the ectodomain conformation of the human immunodeficiency virus (HIV-1) envelope glycoprotein. Nguyen HT; Madani N; Ding H; Elder E; Princiotto A; Gu C; Darby P; Alin J; Herschhorn A; Kappes JC; Mao Y; Sodroski JG Virol J; 2017 Feb; 14(1):33. PubMed ID: 28209172 [TBL] [Abstract][Full Text] [Related]
32. Low complexity regions (LCRs) contribute to the hypervariability of the HIV-1 gp120 protein. María Velasco A; Becerra A; Hernández-Morales R; Delaye L; Jiménez-Corona ME; Ponce-de-Leon S; Lazcano A J Theor Biol; 2013 Dec; 338():80-6. PubMed ID: 24021867 [TBL] [Abstract][Full Text] [Related]
33. Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage. Verrier F; Borman AM; Brand D; Girard M AIDS Res Hum Retroviruses; 1999 May; 15(8):731-43. PubMed ID: 10357469 [TBL] [Abstract][Full Text] [Related]
34. Glycan deletions in the HIV-1 gp120 V1/V2 domain compromise viral infectivity, sensitize the mutant virus strains to carbohydrate-binding agents and represent a specific target for therapeutic intervention. Auwerx J; François KO; Covens K; Van Laethem K; Balzarini J Virology; 2008 Dec; 382(1):10-9. PubMed ID: 18930512 [TBL] [Abstract][Full Text] [Related]
35. Caprine arthritis-encephalitis virus envelope surface glycoprotein regions interacting with the transmembrane glycoprotein: structural and functional parallels with human immunodeficiency virus type 1 gp120. Hötzel I; Cheevers WP J Virol; 2003 Nov; 77(21):11578-87. PubMed ID: 14557643 [TBL] [Abstract][Full Text] [Related]
36. Importance of conformation on the neutralizing antibody response to HIV-1 gp120. Steimer KS; Haigwood NL Biotechnol Ther; 1991; 2(1-2):63-89. PubMed ID: 1726963 [TBL] [Abstract][Full Text] [Related]
37. Structural Analysis of the Glycosylated Intact HIV-1 gp120-b12 Antibody Complex Using Hydroxyl Radical Protein Footprinting. Li X; Grant OC; Ito K; Wallace A; Wang S; Zhao P; Wells L; Lu S; Woods RJ; Sharp JS Biochemistry; 2017 Feb; 56(7):957-970. PubMed ID: 28102671 [TBL] [Abstract][Full Text] [Related]
38. Determination of essential amino acids involved in the CD4-independent tropism of the X4 human immunodeficiency virus type 1 m7NDK isolate: role of potential N glycosylations in the C2 and V3 regions of gp120. Dumonceaux J; Goujon C; Joliot V; Briand P; Hazan U J Virol; 2001 Jun; 75(11):5425-8. PubMed ID: 11333929 [TBL] [Abstract][Full Text] [Related]
39. Role of the HIV gp120 conserved domain 5 in processing and viral entry. Sen J; Jacobs A; Caffrey M Biochemistry; 2008 Jul; 47(30):7788-95. PubMed ID: 18597484 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of V3-specific cleavage of recombinant HIV-1 gp120 produced in Chinese hamster ovary cells. Du SX; Xu L; Viswanathan S; Whalen RG Protein Expr Purif; 2008 Jun; 59(2):223-31. PubMed ID: 18406166 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]